Latest net tangible assets for 7607.TWO: $42M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
DuoGenic StemCells corporation (7607.TWO) currently reports a net tangible assets of $42M as of June 2026. That compares with $18M in the prior-year period — up 127.1% year over year. Use the charts on this page to explore DuoGenic StemCells corporation's net tangible assets history and peer comparisons.
DuoGenic StemCells corporation's net tangible assets increased from $18M to $42M — a 127.1% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
DuoGenic StemCells corporation reported $42M in net tangible assets as of June 2026. That compares with $18M in the prior-year period — up 127.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current net tangible assets of $42M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for DuoGenic StemCells corporation, and consider following 7607.TWO for alerts when major investors trade the stock.